Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cyclophosphamide 500 mg injection'
(id=6898819 ; fe=en:cyclophosphamide 500 mg injection ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1933 creation date=2017-06-25 touchdate=2025-04-26 19:15:46.000)
≈ 56 relations sortantes

  1. en:cyclophosphamide 500 mg injection -- r_associated #0: 43 / 1 -> en:mechlorethamine hydrochloride 10mg injection
    n1=en:cyclophosphamide 500 mg injection | n2=en:mechlorethamine hydrochloride 10mg injection | rel=r_associated | relid=0 | w=43
  2. en:cyclophosphamide 500 mg injection -- r_associated #0: 43 / 1 -> en:temozolomide 100mg powder for injection
    n1=en:cyclophosphamide 500 mg injection | n2=en:temozolomide 100mg powder for injection | rel=r_associated | relid=0 | w=43
  3. en:cyclophosphamide 500 mg injection -- r_associated #0: 41 / 0.953 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=en:cyclophosphamide 500 mg injection | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=41
  4. en:cyclophosphamide 500 mg injection -- r_associated #0: 39 / 0.907 -> en:carmustine 100mg powder and solvent for infusion vial
    n1=en:cyclophosphamide 500 mg injection | n2=en:carmustine 100mg powder and solvent for infusion vial | rel=r_associated | relid=0 | w=39
  5. en:cyclophosphamide 500 mg injection -- r_associated #0: 35 / 0.814 -> en:alkylating activity [moa]
    n1=en:cyclophosphamide 500 mg injection | n2=en:alkylating activity [moa] | rel=r_associated | relid=0 | w=35
  6. en:cyclophosphamide 500 mg injection -- r_associated #0: 35 / 0.814 -> en:injectable solution dosage form
    n1=en:cyclophosphamide 500 mg injection | n2=en:injectable solution dosage form | rel=r_associated | relid=0 | w=35
  7. en:cyclophosphamide 500 mg injection -- r_associated #0: 35 / 0.814 -> en:temozolomide 20mg capsule
    n1=en:cyclophosphamide 500 mg injection | n2=en:temozolomide 20mg capsule | rel=r_associated | relid=0 | w=35
  8. en:cyclophosphamide 500 mg injection -- r_associated #0: 34 / 0.791 -> en:cyclophosphamide 2000 mg injection
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 2000 mg injection | rel=r_associated | relid=0 | w=34
  9. en:cyclophosphamide 500 mg injection -- r_associated #0: 34 / 0.791 -> en:methylene dimethane sulfonate
    n1=en:cyclophosphamide 500 mg injection | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=34
  10. en:cyclophosphamide 500 mg injection -- r_associated #0: 32 / 0.744 -> en:amustaline
    n1=en:cyclophosphamide 500 mg injection | n2=en:amustaline | rel=r_associated | relid=0 | w=32
  11. en:cyclophosphamide 500 mg injection -- r_associated #0: 32 / 0.744 -> en:bi-functional alkylating agent val-083
    n1=en:cyclophosphamide 500 mg injection | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=32
  12. en:cyclophosphamide 500 mg injection -- r_associated #0: 32 / 0.744 -> en:platinum compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:platinum compound | rel=r_associated | relid=0 | w=32
  13. en:cyclophosphamide 500 mg injection -- r_associated #0: 32 / 0.744 -> en:thiotepa 15mg injection (pdr for recon)
    n1=en:cyclophosphamide 500 mg injection | n2=en:thiotepa 15mg injection (pdr for recon) | rel=r_associated | relid=0 | w=32
  14. en:cyclophosphamide 500 mg injection -- r_associated #0: 31 / 0.721 -> en:cyclophosphamide 50mg tablet
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 50mg tablet | rel=r_associated | relid=0 | w=31
  15. en:cyclophosphamide 500 mg injection -- r_associated #0: 31 / 0.721 -> en:ritrosulfan
    n1=en:cyclophosphamide 500 mg injection | n2=en:ritrosulfan | rel=r_associated | relid=0 | w=31
  16. en:cyclophosphamide 500 mg injection -- r_associated #0: 30 / 0.698 -> en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution | rel=r_associated | relid=0 | w=30
  17. en:cyclophosphamide 500 mg injection -- r_associated #0: 30 / 0.698 -> en:dm-choc-pen
    n1=en:cyclophosphamide 500 mg injection | n2=en:dm-choc-pen | rel=r_associated | relid=0 | w=30
  18. en:cyclophosphamide 500 mg injection -- r_associated #0: 30 / 0.698 -> en:mitotenamine
    n1=en:cyclophosphamide 500 mg injection | n2=en:mitotenamine | rel=r_associated | relid=0 | w=30
  19. en:cyclophosphamide 500 mg injection -- r_associated #0: 30 / 0.698 -> en:nitrosourea compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:nitrosourea compound | rel=r_associated | relid=0 | w=30
  20. en:cyclophosphamide 500 mg injection -- r_associated #0: 30 / 0.698 -> en:piperazinedione
    n1=en:cyclophosphamide 500 mg injection | n2=en:piperazinedione | rel=r_associated | relid=0 | w=30
  21. en:cyclophosphamide 500 mg injection -- r_associated #0: 29 / 0.674 -> en:bendamustine 100mg powder for injection solution 20ml vial
    n1=en:cyclophosphamide 500 mg injection | n2=en:bendamustine 100mg powder for injection solution 20ml vial | rel=r_associated | relid=0 | w=29
  22. en:cyclophosphamide 500 mg injection -- r_associated #0: 29 / 0.674 -> en:cyclophosphamide / mannitol
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide / mannitol | rel=r_associated | relid=0 | w=29
  23. en:cyclophosphamide 500 mg injection -- r_associated #0: 29 / 0.674 -> en:cyclophosphamide anhydrous
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide anhydrous | rel=r_associated | relid=0 | w=29
  24. en:cyclophosphamide 500 mg injection -- r_associated #0: 28 / 0.651 -> en:ifosfamide 1g powder for infusion solution vial
    n1=en:cyclophosphamide 500 mg injection | n2=en:ifosfamide 1g powder for infusion solution vial | rel=r_associated | relid=0 | w=28
  25. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:asaley
    n1=en:cyclophosphamide 500 mg injection | n2=en:asaley | rel=r_associated | relid=0 | w=27
  26. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:ethylenimine compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:ethylenimine compound | rel=r_associated | relid=0 | w=27
  27. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:irofulven
    n1=en:cyclophosphamide 500 mg injection | n2=en:irofulven | rel=r_associated | relid=0 | w=27
  28. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:lomustine 10mg capsule
    n1=en:cyclophosphamide 500 mg injection | n2=en:lomustine 10mg capsule | rel=r_associated | relid=0 | w=27
  29. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:triazene compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:triazene compound | rel=r_associated | relid=0 | w=27
  30. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> en:uracil mustard 1 mg oral capsule
    n1=en:cyclophosphamide 500 mg injection | n2=en:uracil mustard 1 mg oral capsule | rel=r_associated | relid=0 | w=27
  31. en:cyclophosphamide 500 mg injection -- r_associated #0: 27 / 0.628 -> injection
    n1=en:cyclophosphamide 500 mg injection | n2=injection | rel=r_associated | relid=0 | w=27
  32. en:cyclophosphamide 500 mg injection -- r_associated #0: 26 / 0.605 -> en:cyclophosphamide 1000 mg injection
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 1000 mg injection | rel=r_associated | relid=0 | w=26
  33. en:cyclophosphamide 500 mg injection -- r_associated #0: 25 / 0.581 -> en:cyclophosphamide
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=25
  34. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> allergie à un médicament
    n1=en:cyclophosphamide 500 mg injection | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  35. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> allergie aux médicaments
    n1=en:cyclophosphamide 500 mg injection | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  36. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> allergie médicamenteuse
    n1=en:cyclophosphamide 500 mg injection | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  37. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:amustaline dihydrochloride
    n1=en:cyclophosphamide 500 mg injection | n2=en:amustaline dihydrochloride | rel=r_associated | relid=0 | w=20
  38. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:aziridinylbenzoquinone rh1
    n1=en:cyclophosphamide 500 mg injection | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=20
  39. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:busulfan 2mg tablet
    n1=en:cyclophosphamide 500 mg injection | n2=en:busulfan 2mg tablet | rel=r_associated | relid=0 | w=20
  40. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:cyclophosphamide 100mg/vil inj
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 100mg/vil inj | rel=r_associated | relid=0 | w=20
  41. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:cyclophosphamide 200mg/vil inj
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 200mg/vil inj | rel=r_associated | relid=0 | w=20
  42. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:cyclophosphamide 25mg tablet
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 25mg tablet | rel=r_associated | relid=0 | w=20
  43. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:cyclophosphamide 500 mg
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide 500 mg | rel=r_associated | relid=0 | w=20
  44. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:cyclophosphamide-containing product in oral dose form
    n1=en:cyclophosphamide 500 mg injection | n2=en:cyclophosphamide-containing product in oral dose form | rel=r_associated | relid=0 | w=20
  45. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:dibrospidium chloride
    n1=en:cyclophosphamide 500 mg injection | n2=en:dibrospidium chloride | rel=r_associated | relid=0 | w=20
  46. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:drug allergy
    n1=en:cyclophosphamide 500 mg injection | n2=en:drug allergy | rel=r_associated | relid=0 | w=20
  47. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:epoxide compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:epoxide compound | rel=r_associated | relid=0 | w=20
  48. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:laromustine
    n1=en:cyclophosphamide 500 mg injection | n2=en:laromustine | rel=r_associated | relid=0 | w=20
  49. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:lomustine 40mg capsule
    n1=en:cyclophosphamide 500 mg injection | n2=en:lomustine 40mg capsule | rel=r_associated | relid=0 | w=20
  50. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:medicinal allergy
    n1=en:cyclophosphamide 500 mg injection | n2=en:medicinal allergy | rel=r_associated | relid=0 | w=20
  51. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:parenteral form cyclophosphamide
    n1=en:cyclophosphamide 500 mg injection | n2=en:parenteral form cyclophosphamide | rel=r_associated | relid=0 | w=20
  52. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:picoline compound
    n1=en:cyclophosphamide 500 mg injection | n2=en:picoline compound | rel=r_associated | relid=0 | w=20
  53. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:pipobroman
    n1=en:cyclophosphamide 500 mg injection | n2=en:pipobroman | rel=r_associated | relid=0 | w=20
  54. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:pumitepa
    n1=en:cyclophosphamide 500 mg injection | n2=en:pumitepa | rel=r_associated | relid=0 | w=20
  55. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> en:thiodiglycol
    n1=en:cyclophosphamide 500 mg injection | n2=en:thiodiglycol | rel=r_associated | relid=0 | w=20
  56. en:cyclophosphamide 500 mg injection -- r_associated #0: 20 / 0.465 -> pipobroman
    n1=en:cyclophosphamide 500 mg injection | n2=pipobroman | rel=r_associated | relid=0 | w=20
≈ 56 relations entrantes

  1. en:drug allergy --- r_associated #0: 100 --> en:cyclophosphamide 500 mg injection
    n1=en:drug allergy | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=100
  2. allergie aux médicaments --- r_associated #0: 99 --> en:cyclophosphamide 500 mg injection
    n1=allergie aux médicaments | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=99
  3. allergie médicamenteuse --- r_associated #0: 93 --> en:cyclophosphamide 500 mg injection
    n1=allergie médicamenteuse | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=93
  4. allergie à un médicament --- r_associated #0: 90 --> en:cyclophosphamide 500 mg injection
    n1=allergie à un médicament | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=90
  5. pipobroman --- r_associated #0: 88 --> en:cyclophosphamide 500 mg injection
    n1=pipobroman | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=88
  6. en:pipobroman --- r_associated #0: 85 --> en:cyclophosphamide 500 mg injection
    n1=en:pipobroman | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=85
  7. en:cyclophosphamide 200mg/vil inj --- r_associated #0: 39 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 200mg/vil inj | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=39
  8. en:cyclophosphamide 25mg tablet --- r_associated #0: 38 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 25mg tablet | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=38
  9. en:laromustine --- r_associated #0: 38 --> en:cyclophosphamide 500 mg injection
    n1=en:laromustine | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=38
  10. en:thiodiglycol --- r_associated #0: 36 --> en:cyclophosphamide 500 mg injection
    n1=en:thiodiglycol | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=36
  11. en:aziridinylbenzoquinone rh1 --- r_associated #0: 35 --> en:cyclophosphamide 500 mg injection
    n1=en:aziridinylbenzoquinone rh1 | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=35
  12. en:platinum compound --- r_associated #0: 35 --> en:cyclophosphamide 500 mg injection
    n1=en:platinum compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=35
  13. en:pumitepa --- r_associated #0: 35 --> en:cyclophosphamide 500 mg injection
    n1=en:pumitepa | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=35
  14. en:triazene compound --- r_associated #0: 35 --> en:cyclophosphamide 500 mg injection
    n1=en:triazene compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=35
  15. en:bi-functional alkylating agent val-083 --- r_associated #0: 34 --> en:cyclophosphamide 500 mg injection
    n1=en:bi-functional alkylating agent val-083 | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=34
  16. en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution --- r_associated #0: 34 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 20 mg/ml / mannitol 15 mg/ml injectable solution | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=34
  17. en:bendamustine-vorinostat fusion molecule edo-s101 --- r_associated #0: 32 --> en:cyclophosphamide 500 mg injection
    n1=en:bendamustine-vorinostat fusion molecule edo-s101 | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=32
  18. en:cyclophosphamide 100mg/vil inj --- r_associated #0: 32 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 100mg/vil inj | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=32
  19. en:cyclophosphamide 500 mg --- r_associated #0: 32 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 500 mg | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=32
  20. en:dibrospidium chloride --- r_associated #0: 32 --> en:cyclophosphamide 500 mg injection
    n1=en:dibrospidium chloride | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=32
  21. en:lomustine 40mg capsule --- r_associated #0: 31 --> en:cyclophosphamide 500 mg injection
    n1=en:lomustine 40mg capsule | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=31
  22. en:asaley --- r_associated #0: 30 --> en:cyclophosphamide 500 mg injection
    n1=en:asaley | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=30
  23. en:cyclophosphamide 1000 mg injection --- r_associated #0: 30 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 1000 mg injection | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=30
  24. en:cyclophosphamide 50mg tablet --- r_associated #0: 30 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 50mg tablet | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=30
  25. en:epoxide compound --- r_associated #0: 30 --> en:cyclophosphamide 500 mg injection
    n1=en:epoxide compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=30
  26. en:irofulven --- r_associated #0: 30 --> en:cyclophosphamide 500 mg injection
    n1=en:irofulven | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=30
  27. en:cyclophosphamide-containing product in oral dose form --- r_associated #0: 29 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide-containing product in oral dose form | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=29
  28. en:parenteral form cyclophosphamide --- r_associated #0: 29 --> en:cyclophosphamide 500 mg injection
    n1=en:parenteral form cyclophosphamide | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=29
  29. en:amustaline --- r_associated #0: 28 --> en:cyclophosphamide 500 mg injection
    n1=en:amustaline | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=28
  30. en:amustaline dihydrochloride --- r_associated #0: 28 --> en:cyclophosphamide 500 mg injection
    n1=en:amustaline dihydrochloride | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=28
  31. en:medicinal allergy --- r_associated #0: 28 --> en:cyclophosphamide 500 mg injection
    n1=en:medicinal allergy | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=28
  32. en:picoline compound --- r_associated #0: 28 --> en:cyclophosphamide 500 mg injection
    n1=en:picoline compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=28
  33. en:busulfan 2mg tablet --- r_associated #0: 27 --> en:cyclophosphamide 500 mg injection
    n1=en:busulfan 2mg tablet | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=27
  34. en:methylene dimethane sulfonate --- r_associated #0: 27 --> en:cyclophosphamide 500 mg injection
    n1=en:methylene dimethane sulfonate | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=27
  35. en:ritrosulfan --- r_associated #0: 26 --> en:cyclophosphamide 500 mg injection
    n1=en:ritrosulfan | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=26
  36. en:antineoplastic alkylating agent --- r_associated #0: 25 --> en:cyclophosphamide 500 mg injection
    n1=en:antineoplastic alkylating agent | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=25
  37. en:alkylating activity [moa] --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:alkylating activity [moa] | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  38. en:bendamustine 100mg powder for injection solution 20ml vial --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:bendamustine 100mg powder for injection solution 20ml vial | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  39. en:carmustine 100mg powder and solvent for infusion vial --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:carmustine 100mg powder and solvent for infusion vial | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  40. en:cyclophosphamide / mannitol --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide / mannitol | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  41. en:cyclophosphamide 2000 mg injection --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide 2000 mg injection | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  42. en:cyclophosphamide anhydrous --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:cyclophosphamide anhydrous | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  43. en:dm-choc-pen --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:dm-choc-pen | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  44. en:ethylenimine compound --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:ethylenimine compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  45. en:ifosfamide 1g powder for infusion solution vial --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:ifosfamide 1g powder for infusion solution vial | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  46. en:injectable solution dosage form --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:injectable solution dosage form | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  47. en:lomustine 10mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:lomustine 10mg capsule | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  48. en:mechlorethamine hydrochloride 10mg injection --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:mechlorethamine hydrochloride 10mg injection | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  49. en:mitotenamine --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:mitotenamine | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  50. en:nitrosourea compound --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:nitrosourea compound | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  51. en:piperazinedione --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:piperazinedione | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  52. en:temozolomide 100mg powder for injection --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:temozolomide 100mg powder for injection | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  53. en:temozolomide 20mg capsule --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:temozolomide 20mg capsule | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  54. en:thiotepa 15mg injection (pdr for recon) --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:thiotepa 15mg injection (pdr for recon) | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  55. en:uracil mustard 1 mg oral capsule --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=en:uracil mustard 1 mg oral capsule | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
  56. injection --- r_associated #0: 20 --> en:cyclophosphamide 500 mg injection
    n1=injection | n2=en:cyclophosphamide 500 mg injection | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr